![](https://investorshub.advfn.com/uicon/521957.png?cb=1487633345)
Tuesday, June 28, 2016 6:19:03 PM
Great interview, was a great day - I wasn't on the net all day, it is nice to be able to come home, bring up the board, and see all the news.
Brazil is a pure medical play, Bedrocan is a pure medical play -
two distinct separate market segments
what I really like about the last two deals - Bruce is shopping for cheap value the world over. Get 20% of Auscan for advice, get 50% of whatever this Brazil thing is for 'a couple hundred k'
what is this really - we are providing Brazilian universities the cannabis, they will be using Brazilian public funding to do pharmaceutical research on cannabis for the benefit of 200 million Brazilian people - BUT - because we have the Bedrocan strains, we have that intellectual property rights in South America - our upside - we get to go to the rest of the world with this Brazilian research and intellectual property and we get to commercialize it.
He mentioned Parkinson's 2 times - they will be performing disease specific drug trials - just like pharmaceutical companies - I think I hear a bell ringing - DIN DIN DIN
Price is what you pay
Value is what you get
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM